{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:54:50Z","timestamp":1790985290963,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25087-0","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T11:46:43Z","timestamp":1763725603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["RETRACTED ARTICLE: A novel malignant mesothelioma organoids-T cell co-culture platform for personalized immunochemotherapy testing"],"prefix":"10.1038","volume":"15","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songlin","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunshan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenggang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"9","key":"25087_CR1","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1002\/ijc.26229","volume":"130","author":"A Marinaccio","year":"2012","unstructured":"Marinaccio, A. et al. Pleural malignant mesothelioma epidemic: incidence, modalities of asbestos exposure and occupations involved from the Italian National register. Int. J. Cancer. 130 (9), 2146\u20132154 (2012).","journal-title":"Int. J. Cancer"},{"issue":"6","key":"25087_CR2","first-page":"e20210129","volume":"47","author":"GNM Hajj","year":"2021","unstructured":"Hajj, G. N. M. et al. Malignant pleural mesothelioma: an update. Jornal Brasileiro De Pneumologia: Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia. 47 (6), e20210129 (2021).","journal-title":"Jornal Brasileiro De Pneumologia: Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia"},{"issue":"4","key":"25087_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3892\/mco.2023.2627","volume":"18","author":"S Alaklabi","year":"2023","unstructured":"Alaklabi, S., Roy, A. M., Skitzki, J. J. & Iyer, R. Immunotherapy in malignant peritoneal mesothelioma (Review). Mol. Clin. Oncol. 18 (4), 31 (2023).","journal-title":"Mol. Clin. Oncol."},{"issue":"11","key":"25087_CR4","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s11912-022-01302-3","volume":"24","author":"ND Perera","year":"2022","unstructured":"Perera, N. D. & Mansfield, A. S. The evolving therapeutic landscape for malignant pleural mesothelioma. Curr. Oncol. Rep. 24 (11), 1413\u20131423 (2022).","journal-title":"Curr. Oncol. Rep."},{"issue":"11","key":"25087_CR5","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1097\/JTO.0b013e3181f1cf2b","volume":"5","author":"MT Milano","year":"2010","unstructured":"Milano, M. T. & Zhang, H. Malignant pleural mesothelioma: a population-based study of survival. J. Thorac. Oncology: Official Publication Int. Association Study Lung Cancer. 5 (11), 1841\u20131848 (2010).","journal-title":"J. Thorac. Oncology: Official Publication Int. Association Study Lung Cancer"},{"issue":"26","key":"25087_CR6","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1111\/1759-7714.15022","volume":"14","author":"Q Wang","year":"2023","unstructured":"Wang, Q. et al. Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma. Thorac. Cancer. 14 (26), 2715\u20132731 (2023).","journal-title":"Thorac. Cancer"},{"issue":"12","key":"25087_CR7","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","volume":"8","author":"J Hmeljak","year":"2018","unstructured":"Hmeljak, J. et al. Integrative molecular characterization of malignant pleural mesothelioma. Cancer Discov. 8 (12), 1548\u20131565 (2018).","journal-title":"Cancer Discov."},{"key":"25087_CR8","doi-asserted-by":"publisher","first-page":"e2100422","DOI":"10.1200\/PO.21.00422","volume":"6","author":"I Dagogo-Jack","year":"2022","unstructured":"Dagogo-Jack, I. et al. Molecular characterization of mesothelioma: impact of histologic type and site of origin on molecular landscape. JCO Precision Oncol. 6, e2100422 (2022).","journal-title":"JCO Precision Oncol."},{"issue":"4","key":"25087_CR9","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","volume":"161","author":"M van de Wetering","year":"2015","unstructured":"van de Wetering, M. et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161 (4), 933\u2013945 (2015).","journal-title":"Cell"},{"issue":"5","key":"25087_CR10","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","volume":"25","author":"O Kopper","year":"2019","unstructured":"Kopper, O. et al. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity. Nat. Med. 25 (5), 838\u2013849 (2019).","journal-title":"Nat. Med."},{"issue":"2","key":"25087_CR11","doi-asserted-by":"publisher","first-page":"100911","DOI":"10.1016\/j.xcrm.2022.100911","volume":"4","author":"HM Wang","year":"2023","unstructured":"Wang, H. M. et al. Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study. Cell. Rep. Med. 4 (2), 100911 (2023).","journal-title":"Cell. Rep. Med."},{"issue":"7","key":"25087_CR12","doi-asserted-by":"publisher","first-page":"107116","DOI":"10.1016\/j.isci.2023.107116","volume":"26","author":"Y Tang","year":"2023","unstructured":"Tang, Y. et al. Cutoff value of IC(50) for drug sensitivity in patient-derived tumor organoids in colorectal cancer. iScience 26 (7), 107116 (2023).","journal-title":"iScience"},{"issue":"1","key":"25087_CR13","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1038\/s41598-018-21200-8","volume":"8","author":"AR Mazzocchi","year":"2018","unstructured":"Mazzocchi, A. R., Rajan, S. A. P., Votanopoulos, K. I., Hall, A. R. & Skardal, A. In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening. Sci. Rep. 8 (1), 2886 (2018).","journal-title":"Sci. Rep."},{"issue":"1","key":"25087_CR14","doi-asserted-by":"publisher","first-page":"11640","DOI":"10.1038\/s41598-023-38545-4","volume":"13","author":"SD Forsythe","year":"2023","unstructured":"Forsythe, S. D. et al. Cisplatin exhibits superiority over MMC as a perfusion agent in a peritoneal mesothelioma patient specific organoid HIPEC platform. Sci. Rep. 13 (1), 11640 (2023).","journal-title":"Sci. Rep."},{"issue":"1","key":"25087_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12943-023-01901-z","volume":"23","author":"X Fang","year":"2024","unstructured":"Fang, X. et al. Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma. Mol. Cancer. 23 (1), 12 (2024).","journal-title":"Mol. Cancer"},{"key":"25087_CR16","doi-asserted-by":"publisher","first-page":"107542","DOI":"10.1016\/j.lungcan.2024.107542","volume":"191","author":"AJ Hocking","year":"2024","unstructured":"Hocking, A. J., Mortimer, L. A., Farrall, A. L., Russell, P. A. & Klebe, S. Establishing mesothelioma patient-derived organoid models from malignant pleural effusions. Lung Cancer (Amsterdam Netherlands). 191, 107542 (2024).","journal-title":"Lung Cancer (Amsterdam Netherlands)"},{"issue":"43","key":"25087_CR17","doi-asserted-by":"publisher","first-page":"eadg6686","DOI":"10.1126\/sciadv.adg6686","volume":"9","author":"L Sun","year":"2023","unstructured":"Sun, L. et al. A human mucosal melanoma organoid platform for modeling tumor heterogeneity and exploring immunotherapy combination options. Sci. Adv. 9 (43), eadg6686 (2023).","journal-title":"Sci. Adv."},{"issue":"1","key":"25087_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41596-019-0232-9","volume":"15","author":"CM Cattaneo","year":"2020","unstructured":"Cattaneo, C. M. et al. Tumor organoid-T-cell coculture systems. Nat. Protoc. 15 (1), 15\u201339 (2020).","journal-title":"Nat. Protoc."},{"key":"25087_CR19","doi-asserted-by":"crossref","unstructured":"Li, D. et al. An immune subtype classification system enables the development of strategies to predict and enhance immunotherapy responses in colorectal cancer. Cancer Research (2025).","DOI":"10.1158\/0008-5472.29052301"},{"key":"25087_CR20","doi-asserted-by":"publisher","first-page":"216741","DOI":"10.1016\/j.canlet.2024.216741","volume":"588","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Antigen\/HLA-agnostic strategies for characterizing Tumor-responsive T cell receptors in PDAC patients via single-cell sequencing and autologous organoid application. Cancer Lett. 588, 216741 (2024).","journal-title":"Cancer Lett."},{"issue":"1","key":"25087_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13045-022-01278-4","volume":"15","author":"H Xu","year":"2022","unstructured":"Xu, H., Jiao, D., Liu, A. & Wu, K. Tumor organoids: applications in cancer modeling and potentials in precision medicine. J. Hematol. Oncol. 15 (1), 58 (2022).","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"25087_CR22","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1038\/s41467-019-11867-6","volume":"10","author":"M Kim","year":"2019","unstructured":"Kim, M. et al. Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening. Nat. Commun. 10 (1), 3991 (2019).","journal-title":"Nat. Commun."},{"key":"25087_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canlet.2017.11.021","volume":"414","author":"MZ Jin","year":"2018","unstructured":"Jin, M. Z. et al. Organoids: an intermediate modeling platform in precision oncology. Cancer Lett. 414, 174\u2013180 (2018).","journal-title":"Cancer Lett."},{"issue":"1","key":"25087_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","volume":"26","author":"Y Yao","year":"2020","unstructured":"Yao, Y. et al. Patient-Derived organoids predict chemoradiation responses of locally advanced rectal cancer. Cell. Stem cell. 26 (1), 17\u201326e16 (2020).","journal-title":"Cell. Stem cell."},{"key":"25087_CR25","doi-asserted-by":"publisher","first-page":"104285","DOI":"10.1016\/j.critrevonc.2024.104285","volume":"195","author":"S Seghers","year":"2024","unstructured":"Seghers, S. et al. A systematic review of patient-derived tumor organoids generation from malignant effusions. Crit. Rev. Oncol. Hematol. 195, 104285 (2024).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"25087_CR26","first-page":"9390912","volume":"2022","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Combining organoid models with next-generation sequencing to reveal tumor heterogeneity and predict therapeutic response in breast cancer. J. Oncol. 2022, 9390912 (2022).","journal-title":"J. Oncol."},{"issue":"3","key":"25087_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41587-019-0048-8","volume":"37","author":"F Schutgens","year":"2019","unstructured":"Schutgens, F. et al. Tubuloids derived from human adult kidney and urine for personalized disease modeling. Nat. Biotechnol. 37 (3), 303\u2013313 (2019).","journal-title":"Nat. Biotechnol."},{"key":"25087_CR28","doi-asserted-by":"crossref","unstructured":"Walz, S. et al. A protocol for organoids from the urine of bladder cancer patients. Cells 12(17) (2023).","DOI":"10.3390\/cells12172188"},{"issue":"1","key":"25087_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13046-022-02263-y","volume":"41","author":"ML De Angelis","year":"2022","unstructured":"De Angelis, M. L. et al. An organoid model of colorectal Circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile. J. Experimental Clin. Cancer Research: CR. 41 (1), 86 (2022).","journal-title":"J. Experimental Clin. Cancer Research: CR"},{"issue":"4","key":"25087_CR30","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.4143\/crt.2022.1630","volume":"55","author":"W Choi","year":"2023","unstructured":"Choi, W. et al. Establishment of Patient-Derived organoids using ascitic or pleural fluid from cancer patients. Cancer Res. Treat. 55 (4), 1077\u20131086 (2023).","journal-title":"Cancer Res. Treat."}],"updated-by":[{"DOI":"10.1038\/s41598-026-65143-x","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25087-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25087-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25087-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:43:44Z","timestamp":1785854624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25087-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25087"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25087-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: In the original version of this Article: Yang Liu and Yang Yang were omitted asequally contributing authors. A statement has now been added and reads: \u201cYang Liu and Yang Yang contributed equally to this work\u201d.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-65143-x","URL":"https:\/\/doi.org\/10.1038\/s41598-026-65143-x","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"41305"}}